Publications by authors named "Frederick Howard"

Claim this Profile
R
Retrospective evaluation of adjuvant capecitabine dosing patterns in triple negative breast cancer.
Kun Lin, Elena Michaels, Eric Polley, Peter H O'Donnell, Frederick M Howard

J Oncol Pharm Pract· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating social science into oral health and dental research: a narrative review.
Frederick Howard, Nawal Jama, Duangporn Duangthip

Front Oral Health· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine Learning-Based Prediction of Distant Recurrence Risk and Ribociclib Treatment Effect in HR+/HER2- Early Breast Cancer Using Real-World and NATALEE Data.
Frederick M Howard, Peter A Fasching, Cesar A Santa-Maria, Elgene Lim, Joseph A Sparano

Clin Cancer Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Analysis of AI foundation model features decodes the histopathologic landscape of HPV-positive head and neck squamous cell carcinomas". [Oral Oncol. 163 (2025) 107207].
Hanna M Hieromnimon, Anna Trzcinska, Frank T Wen, Frederick M Howard, James M Dolezal

Oral Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rethinking Treatment Priorities in Estrogen Receptor-Low Breast Cancer.
Jincong Q Freeman, Rita Nanda, Frederick M Howard

J Clin Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virtual multiplex immunofluorescence identifies lymphocyte subsets predictive of response to neoadjuvant therapy.
Anran Li, Madeleine Torcasso, Anna Woodard, Hanna Hieromnimon, Jonathan Trujillo, Frederick M Howard

Ther Adv Med Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Building digital histology models of transcriptional tumor programs with generative deep learning for pathology-based precision medicine.
Hanna M Hieromnimon, James Dolezal, Kristina Doytcheva, Frederick M Howard, Sara Kochanny

Genome Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integration of Gene Expression and Digital Histology to Predict Treatment-Specific Responses in Breast Cancer.
Frederick M Howard, James Dolezal, Hanna Hieromnimon, Sara Venters, Sara Kochanny

medRxiv· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized phase II trial of nab-paclitaxel with or without mifepristone for advanced triple-negative breast cancer.
Nan Chen, Margarite Matossian, Poornima Saha, Murtuza Rampurwala, Salaija Kamaraju, Frederick M Howard

Breast Cancer Res Treat· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep Learning on Histopathological Images to Predict Breast Cancer Recurrence Risk and Chemotherapy Benefit.
Gil Shamai, Shachar Cohen, Yoav Binenbaum, Edmond Sabo, Alexandra Cretu, Frederick M Howard

medRxiv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of AI foundation model features decodes the histopathologic landscape of HPV-positive head and neck squamous cell carcinomas.
Hanna M Hieromnimon, Anna Trzcinska, Frank T Wen, Frederick M Howard, James M Dolezal

Oral Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends and Disparities in the Use of Immunotherapy for Triple-Negative Breast Cancer in the US.
Jincong Q Freeman, Dezheng Huo, Sarah P Shubeck, Nan Chen, Sudha R Yarlagadda, Frederick M Howard

JAMA Netw Open· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative Biomarkers, Genomic Assays, and Demographics Associated with Breast-Conserving Surgery Following Neoadjuvant Therapy in Early-Stage, Hormone Receptor-Positive, HER-Negative Breast Cancer.
Jincong Q Freeman, Sarah P Shubeck, Nan Chen, Sudha R Yarlagadda, Rita Nanda, Frederick M Howard

Ann Surg Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Datopotamab-deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial.
Rebecca A Shatsky, Meghna S Trivedi, Christina Yau, Rita Nanda, Hope S Rugo, Frederick M Howard

Nat Med· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASO Author Reflections: Breast-Conserving Surgery After Neoadjuvant Systemic Therapy for Early-Stage Breast Cancer: Quantitative Biomarkers and Disparities in the Precision-Medicine Era.
Jincong Q Freeman, Dezheng Huo, Frederick M Howard

Ann Surg Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of cyclin-dependent kinase 4/6 inhibitor-induced serum creatinine elevations in patients with hormone receptor positive breast cancer.
Emily Ly, Frederick M Howard, Nan Chen, Olwen Hahn, Gini F Fleming

J Oncol Pharm Pract· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generative adversarial networks accurately reconstruct pan-cancer histology from pathologic, genomic, and radiographic latent features.
Frederick M Howard, Hanna M Hieromnimon, Siddhi Ramesh, James Dolezal, Sara Kochanny

Sci Adv· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting pathologic complete response to neoadjuvant chemotherapy in breast cancer using a machine learning approach.
Fangyuan Zhao, Eric Polley, Julian McClellan, Frederick Howard, Olufunmilayo I Olopade

Breast Cancer Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing a low-cost, open-source, locally manufactured workstation and computational pipeline for automated histopathology evaluation using deep learning.
Divya Choudhury, James M Dolezal, Emma Dyer, Sara Kochanny, Siddhi Ramesh, Frederick M Howard

EBioMedicine· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the Relationship Between Neighborhood Socioeconomic Disadvantage and Telemedicine Use Among Patients With Breast Cancer and Examining Differential Provisions of Oncology Services Between Telehealth and In-Person Visits: Quantitative Study.
Jincong Q Freeman, Fangyuan Zhao, Frederick M Howard, Rita Nanda, Olufunmilayo I Olopade

JMIR Cancer· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a clinical breast cancer tool for accurate prediction of recurrence.
Asim Dhungana, Augustin Vannier, Fangyuan Zhao, Jincong Q Freeman, Poornima Saha, Frederick M Howard

NPJ Breast Cancer· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of large language models as a diagnostic aid for complex medical cases.
Alejandro Ríos-Hoyo, Naing Lin Shan, Anran Li, Alexander T Pearson, Lajos Pusztai, Frederick M Howard

Front Med (Lausanne)· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterizing the Increase in Artificial Intelligence Content Detection in Oncology Scientific Abstracts From 2021 to 2023.
Frederick M Howard, Anran Li, Mark F Riffon, Elizabeth Garrett-Mayer, Alexander T Pearson

JCO Clin Cancer Inform· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Slideflow: deep learning for digital histopathology with real-time whole-slide visualization.
James M Dolezal, Sara Kochanny, Emma Dyer, Siddhi Ramesh, Andrew Srisuwananukorn, Frederick M Howard

BMC Bioinformatics· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generative Adversarial Networks Accurately Reconstruct Pan-Cancer Histology from Pathologic, Genomic, and Radiographic Latent Features.
Frederick M Howard, Hanna M Hieromnimon, Siddhi Ramesh, James Dolezal, Sara Kochanny

bioRxiv· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis